Showing 5041-5050 of 5693 results for "".
- NYU Med School Will Graduate Students Early to Help New York Fight Coronavirushttps://modernod.com/news/nyu-med-school-will-graduate-students-early-to-help-new-york-fight-coronavirus/2477471/As COVID-19 continues to slam New York City hospitals, New York University’s Grossman School of Medicine this week took the dramatic step of letting its graduating class depart early to join the response effort, according to a TIME
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- UK Commits £210 Million Toward Global Efforts to Find COVID-19 Vaccinehttps://modernod.com/news/uk-commits-210-million-toward-global-efforts-to-find-covid-19-vaccine/2477469/The UK government said it would contribute £210 million ($255 million) toward international efforts aimed at finding a vaccine against the novel coronavirus, according to a FirstWord report. The funding will be channelled to the Coalition for Epidemic Preparedness Innovations (CEPI), which
- Prevent Blindness Releases Message to Eye Care Patients Regarding the COVID-19 Pandemichttps://modernod.com/news/prevent-blindness-releases-message-to-eye-care-patients-regarding-the-covid-19-pandemic/2477470/In response to the numerous queries from patients and caregivers, Prevent Blindness has issued the following statement in regards to eye care during the coronavirus pandemic. “For everyone’s health and s
- Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infectionhttps://modernod.com/news/aldeyra-to-screen-clinical-stage-compounds-for-activity-in-covid-19-infection/2477461/Aldeyra Therapeutics announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for potential anti-inflammatory and antiviral activity in the treatment of COVID-19 infection. ADX-629 and reproxalap are structur
- MicroSurgical Technology (MST) Announces the Acquisition of IP and Assets of IRISS Medical Technologies Limitedhttps://modernod.com/news/microsurgical-technology-mst-announces-the-acquisition-of-ip-and-assets-of-iriss-medical-technologies-limited/2477460/MicroSurgical Technology (MST) has acquired the IP and assets of IRISS Medical Technologies Limited, a United Kingdom private limited company, related to the Volk Eye Check product and additional technology and intellectual property. Terms of the deal were not disclosed. The Volk E
- American College of Surgeons Releases New Clinical Guidance Document For Elective Surgical Case Triage During COVID-19https://modernod.com/news/american-college-of-surgeons-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19/2477456/To assist in surgical decision-making in curtailing cases, The American College of Surgeons (ACS) released “COVID-19: Elective Case Triage Guidelines for Surgical Care,” a new surgical triage document that was developed following expert review in several specialties and provides trust
- Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officerhttps://modernod.com/news/iveric-bio-appoints-pravin-u-dugel-md-as-executive-vice-president-and-chief-strategy-and-business-officer/2477448/Iveric bio announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer, effective April 1, 2020. In this role, Dr. Dugel will help shape Iveric bio’s business development strategy going forward. Dr. Dugel brings more than 25 years’ experie
- Working With BARDA and FDA on COVID-19 Countermeasureshttps://modernod.com/news/covid-19-working-with-barda-and-fda-on-covid-19-countermeasures/2477443/How can biotech and pharmaceutical companies work with the government in developing and supplying effective diagnostics, treatments and vaccines for COVID-19? What should these companies know? Join Arnold & Porter on Thursday, March 26 from 12–2 pm Eastern Time for an introduction to c
- FDA Approves Genentech’s Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/fda-approves-genentechs-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/2477442/Genentech announced Monday that the FDA has approved a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standar